Skip to main content
Menu
search

Constructing Capabilities: Holistic Infrastructure Development in Decentralized Manufacturing

Constructing Capabilities: Holistic Infrastructure Development in Decentralized Manufacturing

Industry:
Biopharma

Type:
Podcast

Location:
Miami, Florida

This fifth and final panel with Sean Bartholomew (Biopharma Applications Engineer, Germfree) and Grayson Heller (COO, cGMPnow) discuss the considerations for decentralized cell therapy manufacturing. The key points include the importance of designing identical and cloned processes, focusing on a copy-paste model for multiple locations.

You might also be interested in

View all videos
Regulating the Shift: Quality and Compliance in Decentralized Drug Production
Regulating the Shift: Quality and Compliance in Decentralized Drug ProductionArticles

Regulating the Shift: Quality and Compliance in Decentralized Drug Production

Explore how decentralized drug production is evolving with quality systems, FDA/MHRA guidance, and digital innovations.
Accelerating Access to Life-Saving Cell Therapies
Accelerating Access to Life-Saving Cell TherapiesVideo

Accelerating Access to Life-Saving Cell Therapies

In this IBTV Spotlight from Advanced Therapies Week 2025, Georgi Makin hosts a crucial conversation with Sean Bartholomew, Edwin Stone, and Shannon Eaker on how the industry can overcome these…
Considering Clinical Readiness
Considering Clinical ReadinessVideo

Considering Clinical Readiness

In this expert discussion, Josh Ludwig (ScaleReady), Carol Houts (Germfree), Heather Purvis (Title21), and Priya Baraniak (OrganaBio) explore the urgent need for clinical readiness in cell and gene therapy delivery.

Contact us: Let's unlock your scientific potential together

Complete our contact form and a member of our commercial team will contact you within 24 hours.

White email icon on a green diamond
Service & support: cs@germfree.com
Contact us